CCR 3: Annual Meeting of the Clinical Research Development Unit of Shahid Rajaei Educational and Medical Center

Código QR

CCR 3: Annual Meeting of the Clinical Research Development Unit of Shahid Rajaei Educational and Medical Center

Guardado en:

Detalles Bibliográficos
Autores principales:	Hossein Karim, Shahrooz Yazdani, Morteza Nazari, Maryam Fadaei Dashti, Fatemeh Sehati, Fatemeh Rahimi, Mohammad Zibaei
Formato:	article
Lenguaje:	EN
Publicado:	Alborz University of Medical Sciences 2020
Materias:	Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/4894bb21c37343a9afc1c5dbea8bc00f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The First Report of Cysticercus fasciolaris From Alborz Province, Iran
por: Abolfazl Miahipour, et al.
Publicado: (2020)

Acute Mesenteric Ischemia in a COVID-19 Patient: Delay in Referral and Recommendation for Surgery
por: Mohammad Hossein Bagheripour, et al.
Publicado: (2021)

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis
por: Mohammad Shehab, et al.
Publicado: (2021)

Impact of early cholecystectomy on the readmission rate in patients with acute gallstone cholangitis: a retrospective single-centre study
por: Bishnu Sapkota, et al.
Publicado: (2021)

Integrated real-time imaging system, ‘IRIS’, Kangaroo feeding tube: a guide to placement and image interpretation
por: Stephen Taylor, et al.
Publicado: (2021)

Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study
por: Peter M Irving, et al.
Publicado: (2021)

Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina
por: Espul C, et al.
Publicado: (2012)

Stopping anti-TNF in CD remitters: pros and cons
por: Edouard Louis
Publicado: (2021)

DEDICATED PSYCHIATRY CLINIC FOR INFLAMMATORY BOWEL DISEASE PATIENTS HAS A POSITIVE IMPACT ON DEPRESSION SCORES
por: Kaleb Bogale, et al.
Publicado: (2021)

Transarterial chemoembolization using iodized oil for unresectable hepatocellular carcinoma: perspective from multistep hepatocarcinogenesis
por: Yoshimitsu K
Publicado: (2014)

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
por: Suad Abdeen, et al.
Publicado: (2011)

New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
por: Chua DL, et al.
Publicado: (2014)

Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
por: Lim TR
Publicado: (2014)

Implementing Collaborative Care Management of Behavioral Health for Patients with Inflammatory Bowel Disease
por: Christine Beran, et al.
Publicado: (2021)

Impact of Diagnostic Delay on Disease Course in Pediatric Versus Adult-onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort
por: Alain M. Schoepfer, et al.
Publicado: (2021)

Update on entecavir in the management of severe forms of Hepatitis B
por: Sacco R
Publicado: (2012)

The Ratio of Platelets to Lymphocytes Predicts the Prognosis of Metastatic Colorectal Cancer: A Review and Meta-Analysis
por: Jinming Wang, et al.
Publicado: (2021)

Incidence of ‘new-onset’ constipation and associated factors during lockdown due to the COVID-19 pandemic
por: Bryan Adrian Priego-Parra, et al.
Publicado: (2021)

Organoid vs In Vivo Mouse Model: Which is Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
por: Shinya Sugimoto, MD, PhD, et al.
Publicado: (2022)

Rebuttal to: Organoid vs Mouse Model: Which is a Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
por: Jordi Guiu, PhD, et al.
Publicado: (2022)

CMGH: The year in review
por: Klaus H. Kaestner, PhD, MS, et al.
Publicado: (2021)

Contents
Publicado: (2021)

Form Follows Function for Local Immune Responses in Pancreatic Cancer
por: Anna L. Means, PhD
Publicado: (2021)

Myeloid Cell Mediated Immune Suppression in Pancreatic CancerSummary
por: Samantha B. Kemp, et al.
Publicado: (2021)

Cover 2 - Tertiary Lymphoid Structures: Hub for Pancreatic Cancer Immune Response
Publicado: (2021)

An Epigenetic Switch Between Differentiation and Proliferation in Hepatoblastoma
por: Jeffrey H. Albrecht, MD
Publicado: (2021)

Editorial Board
Publicado: (2021)

Rebuttal to: In Vivo Studies Should Take Priority When Defining Mechanisms of Intestinal Crypt Morphogenesis
por: Shinya Sugimoto, MD, PhD, et al.
Publicado: (2022)

In Vivo Studies Should Take Priority When Defining Mechanisms of Intestinal Crypt Morphogenesis
por: Jordi Guiu, PhD, et al.
Publicado: (2022)

Elsewhere in the AGA Journals
Publicado: (2021)

Crossing the Rubicon: Adipose Tissue Autophagy Breaks Out NAFLD
por: Jieun Kim, PHD, et al.
Publicado: (2021)

Cover 1 - Goblet Cell and Mucus Barrier Homeostasis Require AGR2
Publicado: (2021)

Selected biochemical and hematological abnormalities in Nigerians with human immunodeficiency virus and hepatitis C virus coinfection
por: Nwokediuko SC, et al.
Publicado: (2011)

Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
por: Degasperi E, et al.
Publicado: (2014)

Insulin-like growth factor binding protein-3 is required for the regulation of rat oval cell proliferation and differentiation in the 2AAF/PHX model
por: Nicole C Steiger-Luther, et al.
Publicado: (2010)

A lipid-rich gestational diet predisposes offspring to nonalcoholic fatty liver disease: a potential sequence of events
por: Hughes AN, et al.
Publicado: (2014)

Interferon-free combination therapies for the treatment of hepatitis C: current insights
por: Holmes JA, et al.
Publicado: (2015)

The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia
por: Danish FA, et al.
Publicado: (2013)

Transient elastography with the XL probe rapidly identifies patients with nonhepatic ascites
por: Mueller S, et al.
Publicado: (2012)

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
por: Roggeri DP, et al.
Publicado: (2015)